학술논문
P110α inhibitor alpelisib exhibits a synergistic effect with pyrotinib and reverses pyrotinib resistant in HER2+ breast cancer
Document Type
Article
Source
In Neoplasia September 2023 43
Subject
Language
ISSN
1476-5586